Sophie Dimonaco

3.5k citations
18 papers · 1.5k indexed · 1 hit paper · h-index 11
Topics
Vasculitis and related conditions (11 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers)Rheumatoid Arthritis Research and Therapies (6 papers)

In The Last Decade

Sophie Dimonaco

17 papers receiving 1.4k citations

Hit Papers

Trial of Tocilizumab in Giant-Cell Arteritis20172026202020232017250500750

Peers

Sophie Dimonaco
Comparison fields: 5 of 69
  • Rheumatology 921
  • Pulmonary and Respiratory Medicine 861
  • Genetics 396
  • Immunology 243
  • Hematology 179
Replace Katie Tuckwell with:
Katie Tuckwell United States
Cheryl Talar‐Williams United States
Žiga Rotar Slovenia
R. Pérez-Álvarez Spain
Kathleen Maksimowicz‐McKinnon United States
Ran Nakashima Japan
Sung Soo Ahn South Korea
M J Cuadrado United Kingdom
Roger Silvestrini Australia
A. González Piñeiro Spain
Sophie Dimonaco relative to Katie Tuckwell United States Katie Tuckwell's profile →
Citations per field
00.5×3.3×
Katie Tuckwell · 1×
Citations per year

Countries citing papers authored by Sophie Dimonaco

Since Specialization
Citations

This map shows the geographic impact of Sophie Dimonaco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Dimonaco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Dimonaco more than expected).

Fields of papers citing papers by Sophie Dimonaco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Dimonaco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Dimonaco. The network helps show where Sophie Dimonaco may publish in the future.

Co-authorship network of co-authors of Sophie Dimonaco

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Dimonaco. A scholar is included among the top collaborators of Sophie Dimonaco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Dimonaco. Sophie Dimonaco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 62
2 32
3 2
4 66
5 62
6 1
7 2
8
Trial of Tocilizumab in Giant-Cell Arteritisbreakdown →
815
9 63
10 2
11 59
12
Baseline data on patients enrolled in a randomized, double-masked trial of tocilizumab in giant cell arteritis
1
13 54
14 66
15 4
16 143
17 1
18 21

About Sophie Dimonaco

Sophie Dimonaco is a scholar working on Rheumatology, Genetics and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Vasculitis and related conditions (11 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). The work is most often cited by research in Rheumatology (921 citations), Genetics (396 citations) and Pulmonary and Respiratory Medicine (861 citations). Sophie Dimonaco has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Neil Collinson, Katie Tuckwell, John H. Stone, Micki Klearman, Daniël Blockmans, Bhaskar Dasgupta, Jürgen Rech, María C. Cid, Elisabeth Brouwer and Carlo Salvarani. Their work appears in journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Investigative Ophthalmology & Visual Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026